COVID-19 Vaccines

COVID-19 Vaccine

Vaccine Eligibility

First and second doses

These individuals are currently eligible for first or second doses of a COVID-19 vaccine.

Dose Eligible population How to access vaccine

1st or 2nd dose (2nd dose must be 8 weeks after 1st dose)

Children must be five years old or older at the time of vaccination. Eligibility is based on date of birth and will be confirmed at the time of vaccination.

Dose Eligible population How to access vaccine

1st or 2nd dose (2nd dose must be 8 weeks after 1st dose)

Check what date you are eligible for a second dose

Individuals who are age 12 and older.

Eligibility is based on date of birth and will be confirmed at the time of the appointment.

Third or booster doses

These individuals are currently eligible for third or booster doses of a COVID-19 vaccine.

Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

Individuals age 18 and older

Eligibility is based on date of birth and will be confirmed at the time of the appointment. Please book an appointment for a date following your 18th birthday.

Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

Pregnant individuals

Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

Designated essential caregivers in congregate settings (such as LTCH/RHs, supportive housing, etc.).
Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

First Nation, Inuit and Metis adults and non-Indigenous household members (age 16 or older at time of vaccine)
Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

Individuals who received a complete series of a viral vector vaccine (two doses of AstraZeneca vaccine or one dose of J & J/Janssen vaccine)

Individuals can receive an mRNA vaccine (Pfizer or Moderna) for a booster dose.

Dose Eligible population How to access vaccine

Booster dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

Health care workers (age 16 or older at time of vaccine) 
List of eligible health care workers (scroll down to Health care worker accordion to review complete list)

Work ID must be shown at vaccine clinic.

Dose Eligible population How to access vaccine

3rd dose, minimum of 8 weeks (56 days) after 2nd dose

Check what date you are eligible for a booster dose

Immunocompromised populations:

  • Individuals with stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome.
  • Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Individuals receiving active treatment (including those who have completed treatment within the last three months) for solid tumour or hematologic malignancies (e.g.: chemotherapy, targeted therapies, immunotherapy).
  • Recipients of solid-organ transplant and taking immunosuppressive therapy.
  • Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Individuals receiving active treatment with the following categories of immunosuppressive therapies, anti-B cell therapies such as monoclonal antibodies targeting CD19 CD20 and CD22 (including those who have completed treatment within 12 months), high dose corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor inhibitors and other biologic agents that are significantly immunosuppressive.
  • Individuals receiving dialysis (hemodialysis or peritoneal dialysis)

Eligible individuals can show a current prescription receipt from a pharmacy or the medication bottle or packaging that includes the date of prescription, their first and last name, and the address and phone number of the pharmacy to receive their third dose of COVID-19 vaccine. See list of eligible immunosuppressive medications. Clinical staff will verify eligibility at vaccine clinics.

If eligible individuals do not have a prescription, or the drug is not listed by Ministry, a referral form from the treating health care provider (doctor, nurse practitioner, specialist, hospital specialty program) must be provided at the clinic to receive a third dose of a COVID-19 vaccine.

Timing of the third dose should be decided with the treating provider in order to optimize immune response and minimize delays in management of underlying conditions.
Dose Eligible population How to access vaccine

3rd dose, minimum of 3 months (84 days) after 2nd dose

Check what date you are eligible for a booster dose

  • Residents of high-risk congregate settings including:
  • long-term care homes
  • high-risk licensed retirement homes
  • First Nations elder care lodges

Seniors living in congregate settings including:

  • retirement homes
  • assisted living facilities
  • chronic care hospitals
  • congregate seniors’ apartment buildings
Registration through facility 

Fourth doses

The following individuals are currently eligible for fourth doses of a COVID-19 vaccine.

Dose Eligible population How to access vaccine

4th dose

Minimum of 3 months (84) after 3rd dose

Residents of high-risk congregate settings including:

  • long-term care homes
  • high-risk licensed retirement homes
  • First Nations elder care lodges

Older adults living in other congregate settings providing assisted-living and health services.

Registration through facility

Individuals eligible for 3-dose primary series of the COVID-19 vaccine are eligible for a fourth dose.

Dose Eligible population How to access vaccine

4th dose

Minimum of 3 months (84) after 3rd dose

Immunocompromised populations:

  • Individuals with stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome.
  • Individuals with moderate to severe primary immunodeficiency (e.g., DiGeorge syndrome, Wiskott-Aldrich syndrome).
  • Individuals receiving active treatment (including those who have completed treatment within the last three months) for solid tumour or hematologic malignancies (e.g.: chemotherapy, targeted therapies, immunotherapy).
  • Recipients of solid-organ transplant and taking immunosuppressive therapy.
  • Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy)
  • Individuals receiving active treatment with the following categories of immunosuppressive therapies, anti-B cell therapies such as monoclonal antibodies targeting CD19 CD20 and CD22 (including those who have completed treatment within 12 months), high dose corticosteroids, alkylating agents, antimetabolites, or tumor-necrosis factor inhibitors and other biologic agents that are significantly immunosuppressive.
  • Individuals receiving dialysis (hemodialysis or peritoneal dialysis)

Eligible individuals can show a current prescription receipt from a pharmacy or the medication bottle or packaging that includes the date of prescription, their first and last name, and the address and phone number of the pharmacy to receive their third dose of COVID-19 vaccine. See list of eligible immunosuppressive medications. Clinical staff will verify eligibility at vaccine clinics.

If eligible individuals do not have a prescription, or the drug is not listed by Ministry, a referral form from the treating health care provider (doctor, nurse practitioner, specialist, hospital specialty program) must be provided at the clinic to receive a third dose of a COVID-19 vaccine.

Timing of the fourth dose should be decided with the treating provider in order to optimize immune response and minimize delays in management of underlying conditions.

Information on the COVID-19 vaccines is evolving but this page will be updated when new information is available.

The most important thing we can all do now is take the time to learn more about the vaccines and make informed choices for ourselves and our families.

To learn more about COVID-19 vaccines:

After vaccination

It is vital that everyone, even those who have been vaccinated, continue practicing public health measures including:  

  • staying home if you have any COVID-19 symptoms
  • getting tested for COVID-19 if you have symptoms or have been in close contact with a confirmed positive case of COVID-19
  • limit contacts as much as possible, with gatherings preferably outdoors and within small groups
  • maintaining a physical distance of 6 feet or 2 meters from others outside of your immediate household
  • wearing a mask or face covering
  • washing hands frequently

How can I help once I get vaccinated?

  • Share your story
  • Tell others why you are getting vaccinated and encourage them to do the same
  • Have conversations about COVID-19 vaccine with family, friends and coworkers
  • Continue to follow public health measures

If you have general questions about the COVID-19 vaccine: